A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease
Public ClinicalTrials.gov record NCT00403286. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Parallel-Group, Dose-Finding Trial to Evaluate the Safety and Efficacy of Fluticasone Propionate Combined With Formoterol Fumarate in Patients With Chronic Obstructive Pulmonary Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to determine the appropriate dose of fluticasone propionate/formoterol fumarate that is closest to Advair Diskus (fluticasone propionate/salmeterol xinafoate using pulmonary function, safety, and levels of study drug in blood plasma in patients with chronic obstructive pulmonary disease.
Study identification
- NCT ID
- NCT00403286
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 457 participants
Conditions and interventions
Conditions
Interventions
- Fluticasone Propionate/Formoterol Fumarate Drug
- Fluticasone Propionate Drug
- Formoterol Fumarate Drug
- Fluticasone Propionate/Salmeterol Xinafoate Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2006 (Type not available)
- Primary completion
- May 2007 (Actual)
- Completion
- May 2007 (Actual)
- Last update posted
- Jun 30, 2009
2006 – 2007
United States locations
- U.S. sites
- 49
- U.S. states
- 28
- U.S. cities
- 47
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35209 | — |
| Research Site | Jasper | Alabama | 35501 | — |
| Research Site | Phoenix | Arizona | 85006 | — |
| Research Site | Buena Park | California | 90620 | — |
| Research Site | Costa Mesa | California | 92626 | — |
| Research Site | Encinitas | California | 92024 | — |
| Research Site | Los Angeles | California | 90095 | — |
| Research Site | San Diego | California | 92120 | — |
| Research Site | Wheat Ridge | Colorado | 80033 | — |
| Research Site | Clearwater | Florida | 33765 | — |
| Research Site | DeLand | Florida | 32720 | — |
| Research Site | Tamarac | Florida | 33321 | — |
| Research Site | Tampa | Florida | 33603 | — |
| Research Site | Atlanta | Georgia | 30309 | — |
| Research Site | Woodstock | Georgia | 30189 | — |
| Research Site | Coeur d'Alene | Idaho | 83814 | — |
| Research Site | Hines | Illinois | 60141 | — |
| Research Site | Lenexa | Kansas | 66219 | — |
| Research Site | Topeka | Kansas | 66606 | — |
| Research Site | Madisonville | Kentucky | 42431 | — |
| Research Site | Wheaton | Maryland | 20902 | — |
| Research Site | Minneapolis | Minnesota | 55402 | — |
| Research Site | Saint Charles | Missouri | 63301 | — |
| Research Site | St Louis | Missouri | 63122 | — |
| Research Site | Henderson | Nevada | 89014 | — |
| Research Site | Cherry Hill | New Jersey | 08003 | — |
| Research Site | Albuquerque | New Mexico | 87108 | — |
| Research Site | Camillus | New York | 13031 | — |
| Research Site | Liverpool | New York | 13088 | — |
| Research Site | Charlotte | North Carolina | 28207 | — |
| Research Site | Greenville | North Carolina | 29615 | — |
| Research Site | Morrisville | North Carolina | 27560 | — |
| Research Site | Raleigh | North Carolina | 27607 | — |
| Research Site | Cincinnati | Ohio | 45227 | — |
| Research Site | Cincinnati | Ohio | 45231 | — |
| Research Site | Cincinnati | Ohio | 45242 | — |
| Research Site | Oklahoma City | Oklahoma | 73104 | — |
| Research Site | Medford | Oregon | 97504 | — |
| Research Site | Portland | Oregon | 97213 | — |
| Research Site | East Providence | Rhode Island | 02914 | — |
| Research Site | Spartanburg | South Carolina | 29303 | — |
| Research Site | Austin | Texas | 78750 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | San Antonio | Texas | 78229 | — |
| Research Site | South Burlington | Vermont | 05403 | — |
| Research Site | Abingdon | Virginia | 24210 | — |
| Research Site | Richmond | Virginia | 23225 | — |
| Research Site | Tacoma | Washington | 98405 | — |
| Research Site | Milwaukee | Wisconsin | 53217 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00403286, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 30, 2009 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00403286 live on ClinicalTrials.gov.